Inflammatory alterations in excluded colon in rats: A comparison with chemically induced colitis

Scandinavian Journal of Gastroenterology

Volumn 45, Issue 3, 2010, Pages 315-324

  Longatti, Thamara Sigrist ^a   Acedo, Simone Coghetto ^a   De Oliveira, Caroline Candida ^a   Da Conceição Miranda, Daniel Duarte ^a   Priolli, Denise Gonçalves ^a   Ribeiro, Marcelo Lima ^a   Gambero, Alessandra ^a   Martinez, Carlos Augusto Real ^a  

^a Universidade Sao Francisco Centro de Ciencias Biologicas e da Saude   (Brazil)

Author keywords

Comet assay; Cyclooxygenase 2; Diversion colitis; Inducible nitric oxide synthase; Neutrophils

Indexed keywords

CYCLOOXYGENASE 2; HAPTEN; INDUCIBLE NITRIC OXIDE SYNTHASE; MYELOPEROXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COLITIS; COMPARATIVE STUDY; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVITY; EXPERIMENTAL MODEL; INFLAMMATION; INTESTINE ULCER; LYMPHOID HYPERPLASIA; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; COLITIS; CYCLOOXYGENASE 2; DISEASE MODELS, ANIMAL; INFLAMMATION; MALE; NITRIC OXIDE SYNTHASE; RATS; RATS, WISTAR;

EID: 77149140774     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365520903471572     Document Type: Article

References (34)

1. Glotzer DJ, Glick ME, Goldman H. Proctitis and colitis following diversion of the fecal stream. Gastroenterology 1981;80:438-441
2. Whelan RL, Abramson D, Kim DS, Hashmi HF. Diversion colitis. A prospective study. Surg Endosc 1994;8:19-24.
3. Neut C, Colombel JF, Guillemot F, Cortot A, Gower P, Quandalle P, et al. Impaired bacterial flora in human excluded colon. Gut 1989;30:1094-1098
4. Harig JM, Soergel KH, Komorowski RA, Wood CM. Treatment of diversion colitis with short-chain-fatty acid irrigation. N Engl J Med 1989;320:23-28
5. Tripodi J, Gorcey S, Burakoff R. A case of diversion colitis treated with 5-aminosalicylic acid enemas. Am J Gastroenterol 1992;87:645-647
6. Triantafillidis JK, Nicolakis D, Mountaneas G, Pomonis E. Treatment of diversion colitis with 5-aminosalicylic acid enemas: comparison with betamethasone enemas. Am J Gastroenterol 1991;86:1552-1553
7. Korelitz BI, Cheskin LJ, Sohn N, Sommers SC. Proctitis after fecal diversion in Crohn's disease and its elimination with reanastomosis: implications for surgical management. Report of four cases. Gastroenterology 1984;87:710-713
8. Camacho-Barquero L, Villegas I, Sánchez-Calvo JM, Talero E, Sánchez-Fidalgo S, Motilva V, et al. Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis. Int Immunopharmacol 2007;7:333-342
9. Dos Reis SB, de Oliveira CC, Acedo SC, da Conceição Miranda DD, Ribeiro ML, Pedrazzoli J Jr, et al. Attenuation of colitis injury in rats using Garcinia cambogia extract. Phytother Res 2009;23:324-329
10. Kawada M, Arihiro A, Mizoguchi E. Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease. World J Gastroenterol 2007;13:5581-5593
11. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982;78:206-209
12. Grupta RB, Harpaz N, Itzkowitz S, Hossain S, Matula S, Kornbluth A, et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology 2007;133:1099-1105
13. Pool-Zobel BL, Lotzmann N, Knoll M, Kuchenmeister F, Lambertz R, Leucht U, et al. Detection of genotoxic effects in human gastric and nasal mucosa cells isolated from biopsy samples. Environ Mol Mutagen 1994;24:23-45.
14. Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, et al. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 2000;35:206-221
15. Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 1988;175:184-191
16. Wallace JL, McKnight W, Asfaha S, Liu DY. Reduction of acute and reactivated colitis in rats by an inhibitor of neutrophil activation. Am J Physiol 1998;274:G802-8.
17. Naito Y, Takagi T, Yoshikawa T. Neutrophil-dependent oxidative stress in ulcerative colitis. J Clin Biochem Nutr 2007;41:18-26.
18. Hollenbach E, Vieth M, Roessner A, Neumann M, Malfertheiner P, Naumann M. Inhibition of RICK/nuclear factor-kappaB and p38 signaling attenuates the inflammatory response in a murine model of Crohn disease. J Biol Chem 2005;280:14981-14988
19. Beck PL, Li Y, Wong J, Chen CW, Keenan CM, Sharkey KA, et al. Inducible nitric oxide synthase from bone marrow-derived cells plays a critical role in regulating colonic inflammation. Gastroenterology 2007;132:1778-1790
20. Sedman PC, Macfie J, Sagar P, Mitchell CJ, May J, Mancey- Jones B, et al. The prevalence of gut translocation in humans. Gastroenterology 1994;107:643-649
21. Tsironi E, Irving PM, Feakins RM, Rampton DS. "Diversion" colitis caused by Clostridium difficile infection: report of a case. Dis Colon Rectum 2006;49:1074-1077
22. Wong JM, de Souza R, Kendall CW, Emam A, Jenkins DJ. Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol 2006;40:235-243
23. Topping DL, Clifton PM. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev 2001;81:1031-1064
24. Tedelind S, Westberg F, Kjerrulf M, Vidal A. Antiinflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. World J Gastroenterol 2007; 13:2826-2832
25. Edwards CM, George B, Warren B. Diversion colitis - new light through old windows. Histopathology 1999;34:1-5.
26. Kiely EM, Ajayi NA, Wheeler RA, Malone M. Diversion procto-colitis: response to treatment with short-chain fatty acids. J Pediatr Surg 2001;36:1514-1517
27. Oliveira-Neto JP, de Aguilar-Nascimento JE. Intraluminal irrigation with fibers improves mucosal inflammation and atrophy in diversion colitis. Nutrition 2004;20:197-199
28. Segain JP, Raingeard de la Bletiere D, Bourreille A, Leray V, Gervois N, Rosales C, et al. Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease. Gut 2000;47:397-403.
29. Luhrs H, Gerke T, Boxberger F, Backhaus K, Melcher R, Scheppach W, et al. Butyrate inhibits interleukin-1-mediated nuclear factor-kappa B activation in human epithelial cells. Dig Dis Sci 2001;46:1968-1973
30. Villanacci V, Talbot IC, Rossi E, Bassotti G. Ischaemia: a pathogenetic clue in diversion colitis? Colorectal Dis 2007;9:601-605
31. Warren BF, Shepherd NA, Bartolo DC, Bradfield JW. Pathology of the defunctioned rectum in ulcerative colitis. Gut 1993;34:514-516
32. Seidelin JB, Nielsen OH. Continuous cytokine exposure of colonic epithelial cells induces DNA damage. Eur J Gastroenterol Hepatol 2005;17:363-369
33. Meira LB, Bugni JM, Green SL, Lee CW, Pang B, Borenshtein D, et al. DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice. J Clin Invest 2008;118:2516-2525
34. Kawanishi S, Hiraku Y, Pinlaor S, Ma N. Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis. Biol Chem 2006;387:365-372